SCHEMBL31216628

SCHEMBL31216628

COC(CCC1CCN(c2ccc(N)cc2F)CC1)OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
MAPT P10636 3/20 0.45
GFER P55789 2/20 0.45
LMNA P02545 1/20 0.45
MAPK1 P28482 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
HTT P42858 1/20 0.40
GAA P10253 4/20 0.37
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ACACB O00763 8/20 0.35
MEN1 O00255 1/20 0.34
THRB P10828 1/20 0.34
NR4A1 P22736 1/20 0.34
KMT2A Q03164 1/20 0.34
PTK2B Q14289 1/20 0.34
DPP4 P27487 1/20 0.34
DPP8 Q6V1X1 1/20 0.34
DPP9 Q86TI2 1/20 0.34
DPP7 Q9UHL4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31216596 0.81 ALDH1A1 (0.52) ALDH1A1MAPTLMNAMAPK1TDP1
SCHEMBL25845423 0.79 ALDH1A1 (0.51) ALDH1A1MAPTGFERLMNAMAPK1
SCHEMBL25584570 0.78 MAPT (0.50) ALDH1A1MAPTGFERLMNAMAPK1
SCHEMBL23823282 0.77 ALDH1A1 (0.49) ALDH1A1MAPTGFERLMNAMAPK1
SCHEMBL20231853 0.76 MAPT (0.54) ALDH1A1MAPTGFERLMNAMAPK1
SCHEMBL29890862 0.76 MAPT (0.54) ALDH1A1MAPTGFERLMNAMAPK1
SCHEMBL30207450 0.74 GPR119 (0.51) SMN1; SMN2DPP4
SCHEMBL3028930 0.74 ALDH1A1 (0.69) ALDH1A1MAPTGFERLMNAMAPK1
SCHEMBL29990084 0.74 ALDH1A1 (0.69) ALDH1A1MAPTGFERLMNAMAPK1
SCHEMBL24735237 0.74 ALDH1A1 (0.48) ALDH1A1MAPTGFERLMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024208256-A1 TARGETED PROTEIN DEGRADATION COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海汇伦医药股份有限公司 2024-10-10 WO disclosed